145 related articles for article (PubMed ID: 23474146)
1. microRNA aberrations in Waldenström macroglobulinemia.
Sacco A; Zhang Y; Maiso P; Manier S; Rossi G; Treon SP; Ghobrial IM; Roccaro AM
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):205-7. PubMed ID: 23474146
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics in Waldenström's macroglobulinemia.
Sacco A; Ghobrial IM; Roccaro AM
Epigenomics; 2010 Oct; 2(5):691-6. PubMed ID: 22122052
[TBL] [Abstract][Full Text] [Related]
3. Key role of microRNAs in Waldenström's macroglobulinemia pathogenesis.
Sacco A; Maiso P; Azab A; Azab F; Zhang Y; Liu Y; Ngo HT; Morgan B; Quang P; Issa G; Ghobrial IM; Roccaro AM
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):109-11. PubMed ID: 21454206
[TBL] [Abstract][Full Text] [Related]
4. Genomic abnormalities of Waldenström macroglobulinemia and related low-grade B-cell lymphomas.
Braggio E; Fonseca R
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):198-201. PubMed ID: 23477936
[TBL] [Abstract][Full Text] [Related]
5. [Molecular basis of Waldenström macroglobulinemia].
Sevčíková S; Novák L; Kubiczková L; Dementyeva E; Ríhová L; Hájek R
Klin Onkol; 2012; 25(6):413-20. PubMed ID: 23301642
[TBL] [Abstract][Full Text] [Related]
6. microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia.
Roccaro AM; Sacco A; Chen C; Runnels J; Leleu X; Azab F; Azab AK; Jia X; Ngo HT; Melhem MR; Burwick N; Varticovski L; Novina CD; Rollins BJ; Anderson KC; Ghobrial IM
Blood; 2009 Apr; 113(18):4391-402. PubMed ID: 19074725
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology.
Sacco A; Issa GC; Zhang Y; Liu Y; Maiso P; Ghobrial IM; Roccaro AM
J Hematol Oncol; 2010 Oct; 3():38. PubMed ID: 20929526
[TBL] [Abstract][Full Text] [Related]
8. Waldenstrom Macroglobulinemia: Genomic Aberrations and Treatment.
Kapoor P; Ansell SM; Braggio E
Cancer Treat Res; 2016; 169():321-361. PubMed ID: 27696269
[TBL] [Abstract][Full Text] [Related]
9. Profiling of circulating exosomal miRNAs in patients with Waldenström Macroglobulinemia.
Bouyssou JM; Liu CJ; Bustoros M; Sklavenitis-Pistofidis R; Aljawai Y; Manier S; Yosef A; Sacco A; Kokubun K; Tsukamoto S; Perilla Glen A; Huynh D; Castillo JJ; Treon SP; Leblond V; Hermine O; Roccaro AM; Ghobrial IM; Capelletti M
PLoS One; 2018; 13(10):e0204589. PubMed ID: 30286096
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course.
Mansoor A; Medeiros LJ; Weber DM; Alexanian R; Hayes K; Jones D; Lai R; Glassman A; Bueso-Ramos CE
Am J Clin Pathol; 2001 Oct; 116(4):543-9. PubMed ID: 11601139
[TBL] [Abstract][Full Text] [Related]
11. Epigenomics in Waldenstrom's macroglobulinaemia.
Sacco A; Fenotti A; Bazzana S; Imberti L; Rossi G; Patterson CJ; Treon SP; Ghobrial IM; Roccaro AM
Best Pract Res Clin Haematol; 2016 Jun; 29(2):156-160. PubMed ID: 27825461
[TBL] [Abstract][Full Text] [Related]
12. Microarray demonstrates different gene expression profiling signatures between Waldenström macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
Trojani A; Greco A; Tedeschi A; Lodola M; Di Camillo B; Ricci F; Turrini M; Varettoni M; Rattotti S; Morra E
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):208-10. PubMed ID: 23477935
[TBL] [Abstract][Full Text] [Related]
13. The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions.
Sacco A; Fenotti A; Affò L; Bazzana S; Russo D; Presta M; Malagola M; Anastasia A; Motta M; Patterson CJ; Rossi G; Imberti L; Treon SP; Ghobrial IM; Roccaro AM
Oncotarget; 2017 May; 8(21):35435-35444. PubMed ID: 28423722
[TBL] [Abstract][Full Text] [Related]
14. Waldenström macroglobulinemia: from biology to treatment.
Sahin I; Leblebjian H; Treon SP; Ghobrial IM
Expert Rev Hematol; 2014 Feb; 7(1):157-68. PubMed ID: 24405328
[TBL] [Abstract][Full Text] [Related]
15. Combination of serum microRNA-320a and microRNA-320b as a marker for Waldenström macroglobulinemia.
Kubiczkova Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Almasi M; Pelcova J; Minarik J; Pika T; Pikalova Z; Scudla V; Krejci M; Adam Z; Pour L; Hajek R; Sevcikova S
Am J Hematol; 2015 Mar; 90(3):E51-2. PubMed ID: 25428891
[No Abstract] [Full Text] [Related]
16. Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia.
Bang SM; Seo JW; Park KU; Kim SJ; Kim K; Kim SH; Cho SR; Kim HC; Song J; Kim JS; Kim KH; Lee JH; Lee JJ; Shin MG; Suh C; Chi HS; Oh DY; Won JH; Kim HJ; Yoon SS; Lee DS;
Cancer Genet Cytogenet; 2010 Mar; 197(2):117-21. PubMed ID: 20193844
[TBL] [Abstract][Full Text] [Related]
17. Novel treatment options for Waldenström macroglobulinemia.
Leblebjian H; Agarwal A; Ghobrial I
Clin Lymphoma Myeloma Leuk; 2013 Sep; 13 Suppl 2(0 2):S310-6. PubMed ID: 24290218
[TBL] [Abstract][Full Text] [Related]
18. Expression of regulatory genes for lymphoplasmacytic cell differentiation in Waldenstrom Macroglobulinemia.
Leleu X; Hunter ZR; Xu L; Roccaro AM; Moreau AS; Santos DD; Hatjiharissi E; Bakthavachalam V; Adamia S; Ho AW; Soumerai J; Patterson CJ; Manning RJ; Hamilton S; Verselis S; Fox E; Carrasco R; Ghobrial IM; Treon SP
Br J Haematol; 2009 Apr; 145(1):59-63. PubMed ID: 19220283
[TBL] [Abstract][Full Text] [Related]
19. Genomics and proteomics in multiple myeloma and Waldenström macroglobulinemia.
Henry T; Fonseca R
Curr Opin Hematol; 2007 Jul; 14(4):369-74. PubMed ID: 17534163
[TBL] [Abstract][Full Text] [Related]
20. The Bone Marrow Microenvironment in Waldenström Macroglobulinemia.
Jalali S; Ansell SM
Hematol Oncol Clin North Am; 2018 Oct; 32(5):777-786. PubMed ID: 30190017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
